Abstracts for poster presentations will be accepted until Friday, 22 February 2019.
Authors will be notified of the acceptance of their abstract by Friday, 22 March 2019.
Presenters are required to register for the conference and pay the appropriate registration fee. The registration deadline for presenters is Friday, 26 April 2019.
Please read all information on this page and ensure you download the A4 abstract submission word template before submitting your abstract.
Poster presentations – You are invited to submit an abstract/s to be reviewed for inclusion in the conference program as a poster presentation. We anticipate that posters will be on display for the duration of the conference with authors in attendance at a specified day/time according to their theme.
Oral presentations selected from posters – A small number of submitted abstracts will be chosen by session chairs for a short oral presentation, based on the scientific quality and potential impact of the abstract submitted. Where a submission is nominated for an oral presentation, the author will be notified by Wednesday 22 May (a month before the meeting). Oral presentations will be 10 minutes duration with 5 minutes for questions.
Please nominate two themes from the following list that is most relevant to your abstract:
|A. P450 mechanisms||N. Pharmacogenetics|
|B. P450 structural biology||O. P450 regulation|
|C. Biophysical approaches||P. P450s in molecular toxicology|
|D.Redox partner or other protein-protein interactions||Q. Human extrahepatic P450s|
|E. Molecular modelling||R. P450s in human physiology and disease|
|F. Novel P450 support systems||S. P450 evolution|
|G. P450 synthetic biology||T. P450 biodiversity (invertebrates and other animals)|
|H. Protein engineering of P450s||U. P450s in plants and plant secondary metabolism|
|I. Biotechnological applications of P450s||V. Terpenoid metabolism|
|J. Bioinformatics||W. P450s in steroid biosynthesis and metabolism|
|K. Novel P450s from microbes||X. P450s in insects / pesticides|
|L. Novel reactions/novel chemistry||Y. Other topics, not elsewhere classified|
|M. P450s in drug and other human xenobiotic metabolism (DMPK)|
Instructions to Authors
Before proceeding to submit your abstract, please read the following author instructions to ensure you have all of the information that will be needed to complete the submission process. Please pay particular attention to these instructions as abstracts that do not conform will be returned for reformatting by the authors.
Abstracts MUST be typed into the following word template
Submission and formatting guidelines
- Abstracts must be submitted via the online abstract submission site.
- Abstracts must be submitted on the A4 word template.
- Please do not change the page margins or any set up features.
- The abstract must fit within the space on the template provided. There is no specific word limit. This includes a figure or table, title, authors and any references.
- The abstract must be one page only.
- The abstract text should be typed in 12 point Calibri font (do not use “bold” type)
- All text, including the title, should be entered in sentence case. Please do not type in CAPITAL LETTERS.
- If inserting colour tables and images into the template, please keep in mind that these may not reproduce well on a monotone printer, so it is preferable that the images used be suitable for black and white printing.
Use sentence case, bold, 14 point Calibri font. The title may be a maximum of 20 words and should concisely encapsulate the work presented in the abstract. Sentence case is when you only capitalise the first letter of the first word in a heading – like you would in a sentence – but proper nouns should also have a capital. Do not use a full stop at the end of your title.
Starting on a new line, leaving one line-space after the title, list the presenting author first (bold and underlined), followed by the other authors. Use a mixture of upper and lower case text, e.g., Geoffrey A Harrison, Peter L McCartney & James H Lennon. Do not use bold or underline for co-authors. The authors names should be linked to the affiliation using a superscript number.
Example: Geoffrey A Harrison1, Roger G Starkey1,2
Starting on a new line, list the authors’ affiliations, linking to the authors with a superscript number.
Example: 1Department of Clinical Pharmacology, Flinders University, Adelaide, Australia, 2School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia
Please leave one line space after the affiliations. Please make sure to include the following components in your abstract: Introduction, Aims, Methods, Results, Discussion and Conclusion. Start each heading on a new line with text immediately following heading and without additional line spacing. If any references are added, include one additional line spacing following the abstract text (see sample of references below).
The abstract should be fully left- and right-justified.
Please avoid statements such as “The results will be discussed”. The text should be as informative as possible.
References should be listed after the abstract text in the order shown in the abstract and should be based on the Harvard style of referencing. They should include authors’ last names followed by initials (use “et al” for three or more authors), year of publication (in brackets), the title of the journal (abbreviated in accordance with Index Medicus), volume number, and the first and last page numbers.
Example: Omura, T. & Sato, R. (1962). A new cytochrome in liver microsomes. J. Biol. Chem., 237, 1375-1376.